Transgene Revenue and Competitors
Estimated Revenue & Valuation
- Transgene's estimated annual revenue is currently $39.5M per year.
- Transgene's estimated revenue per employee is $155,000
Employee Data
- Transgene has 255 Employees.
- Transgene grew their employee count by 0% last year.
Transgene's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chairman and CEO | Reveal Email/Phone |
2 | Chief Business Officer | Reveal Email/Phone |
3 | Investor Relations Analyst & Financial Communications Officer - Dir.Fi. | Reveal Email/Phone |
4 | Head Oncolytic Virus Laboratory | Reveal Email/Phone |
5 | Head Protein science lab | Reveal Email/Phone |
6 | Vp operations pharmaceutiques et pharmacien responsable | Reveal Email/Phone |
7 | Head Vectorology Laboratory | Reveal Email/Phone |
8 | Head Biometry (Biostatistics, Data Management) | Reveal Email/Phone |
9 | EVP, General Counsel & Corporate Secretary | Reveal Email/Phone |
10 | Associate Medical Director | Reveal Email/Phone |
Transgene Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Transgene?
Cancer immunotherapy Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing novel immunotherapies for the treatment of cancer.
keywords:N/A
N/A
Total Funding
255
Number of Employees
$39.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Transgene News
2022-04-17 - Feral alfalfa populations are sustaining and growing | Hay and ...
These populations can act as a reservoir for GM transgenes and aid in gene ... respectively, contained the transgene in 2011 and 2012.
2022-03-30 - Transgene: Availability of Preparatory Documents for the ...
With Transgene's myvac® platform, therapeutic vaccination enters the field of precision medicine with a novel immunotherapy that is fully...
2022-03-22 - Transgene's Board of Directors Strengthens Its Governance ...
Transgene's Board of Directors Strengthens Its Governance and Proposes the Appointment of Dr. Alessandro Riva as Independent Chairman. The roles...
Other Companies in Illkirch-Graffenstaden
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $54.5M | 271 | 2% | N/A |
#2 | $68.7M | 275 | -6% | N/A |
#3 | $56M | 361 | 2% | N/A |